Literature DB >> 24940713

Acute metformin intoxication: 2012 experience of Emergency Departement of Lodi, Italy.

Giulia Acquistapace, Marco Rossi, Mara Garbi, Pablo Cosci, Ciro Canetta, Anna Manelli, Giovanni Ricevuti.   

Abstract

UNLABELLED: Background: Metformin is a biguanide antihyperglycemic agent that decreases insulin resistance. It is removed through renal mechanisms and its clearance is reduced in renal failure. Metformin ingestion should always be considered in the differential diagnosis of any patient with metabolic acidosis and increased lactate level. Hemodialysis and continuous veno-venous hemofiltration (CVVH) are both efficient methods to treat metformin intoxication and correct metabolic abnormalities.
METHODS: Patient 1: A 63-year-old man with type 2 diabetes mellitus presented to emergency department (ED) of Lodi (Italy) for dyspnea. He also reported having diarrhea for 10 days. Initial investigations revealed metabolic acidosis with hyperlactatemia and hypoglycemia (54 mg/dL), metformin concentration was 41 μg/mL (normal value <4 μg/mL). His hemodynamic condition became rapidly unstable and hypotension worsened despite CVVH being performed. Death occurred in 24 h. Patient 2: A 76-year-old man with type 2 diabetes mellitus presented to ED of Lodi for dyspnea. He referred a recent surgery amputation of the left foot's fifth phalanx for osteomyelitis, in levofloxacin therapy. Initial investigations revealed metabolic acidosis with hyperlactatemia and severe hypoglycemia (20 mg/dL). Two hemodialysis sessions were performed with complete normalization of the serum concentration of metformin. RESULTS AND
CONCLUSIONS: In our two cases the genesis of metformin intoxication was clear, powered by acute renal failure, but less obvious was the etiology of acute renal damage responsible for metformin accumulation. Damage due to renal hypoperfusion or the direct toxic effect of metformin should be considered. Additionally, for the second patient, we can also hypothesize that interstitial nephritis was exacerbated by levofloxacin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24940713     DOI: 10.1515/cclm-2014-0208

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 2.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

3.  Toxicokinetics of Metformin During Hemodialysis.

Authors:  Paul Ayoub; Pierre-Olivier Hétu; Monique Cormier; Alexandre Benoit; Andrea Palumbo; Marie-Claude Dubé; Sophie Gosselin; Marc Ghannoum
Journal:  Kidney Int Rep       Date:  2017-03-07

4.  Metformin-Associated Lactic Acidosis Developed as a Result of a Suicidal Attempt.

Authors:  Habibe Zehra Vural; Omer Faruk Koseoglu; Serhat Soylu; Ulku Aygen Turkmen
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-06-15

5.  A patient with metformin-associated lactic acidosis successfully treated with continuous renal replacement therapy: a case report.

Authors:  Hiroki Kinoshita; Machi Yanai; Koichi Ariyoshi; Motozumi Ando; Ryo Tamura
Journal:  J Med Case Rep       Date:  2019-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.